Wang Sizhen is the founder of Genetron Health. Latest round: IPO. Backed by Duke University, Origene Technologies, Share Capital.
Wang Sizhen is the CEO and Co-founder of Genetron Health, a company specializing in cancer molecular profiling. The company utilizes advanced technologies in molecular biology and data science to improve cancer treatment outcomes. Genetron Health aims to transform cancer care from early screening to continuous monitoring.
Full founder directory · Investor directory · Company funding database · Fundraising library